Company Overview
Founded2017
Company Size11-50 employees
IndustryBiotechnology
Last Funding$35M series_b

Elegen

👥 11-50💰 $35,000,000 Series B over 1 year agoBiotechnologyLife ScienceHealth Care💼 Private Company
Website LinkedIn

Elegen is revolutionizing synthetic biology with its innovative DNA synthesis technology. We're creating a new generation of DNA synthesizers that deliver industry-leading DNA lengths (up to 7kb) with exceptional accuracy (99.999%), all within a rapid timeframe. Our ENFINIA DNA product is setting a new standard for the industry. We are well-funded and led by Dr. Matthew Hill, and our mission is to accelerate biomedical advances by solving critical bottlenecks in synthetic biology workflows.

Elegen is revolutionizing synthetic biology with its innovative DNA synthesis technology. We're creating a new generation of DNA synthesizers that deliver industry-leading DNA lengths (up to 7kb) with exceptional accuracy (99.999%), all within a rapid timeframe. Our ENFINIA DNA product is setting a new standard for the industry. We are well-funded and led by Dr. Matthew Hill, and our mission is to accelerate biomedical advances by solving critical bottlenecks in synthetic biology workflows.

Tech Stack
hostingcdnmediansmobile

Related companies:

Jobs at this company:

United StatesFull-TimeDNA SynthesisPosted 22 days ago
Communication SkillsNegotiationLead Generation+4 more